• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Latest News

Connecting COVID-19 Research to Impact on Patients With Atopic Dermatitis
Connecting COVID-19 Research to Impact on Patients With Atopic Dermatitis

March 18th 2024

Two recent studies delve into outcomes of pediatric populations with atopic conditions and an overview of patient outcomes utilizing a Mendelian randomization analysis.

Breaking Down Benzene Testing Methods of Benzoyl Peroxide Products
Breaking Down Benzene Testing Methods of Benzoyl Peroxide Products

March 18th 2024

Advocating for Mohs Surgery in Prison Populations
Advocating for Mohs Surgery in Prison Populations

March 18th 2024

FDA Accepts Journey Medical’s NDA for DFD-29 for Rosacea
FDA Accepts Journey Medical’s NDA for DFD-29 for Rosacea

March 18th 2024

Reviewing Coverage of COVID-19- Related Research in Dermatology From the Past Year
Reviewing Coverage of COVID-19- Related Research in Dermatology From the Past Year

March 18th 2024

Assessing the Relationship Between Psoriasis and Psoriatic Arthritis
Explore Vitiligo Management
Catch Up on What You Missed with Our Live Conference Coverage!
Systemic Therapies for Moderate-to-Severe AD

Conference Coverage

View All
Poster Detailing Safety of JAK Inhibitors Wins Award at AAD Annual Meeting
Poster Detailing Safety of JAK Inhibitors Wins Award at AAD Annual Meeting

March 18th 2024

Jim Lee, MD, PhD, Reflects on New Research at AAD and Advances in Dermatology
Jim Lee, MD, PhD, Reflects on New Research at AAD and Advances in Dermatology

March 14th 2024

Recapping Live Coverage, Interviews, and News From the 2024 American Academy of Dermatology Annual Meeting
Recapping Live Coverage, Interviews, and News From the 2024 American Academy of Dermatology Annual Meeting

March 13th 2024

Q&A: Late-Breaking REMIX-1 and REMIX-2 Data Demonstrated Efficacy of Remibrutinib in Chronic Spontaneous Urticaria
Q&A: Late-Breaking REMIX-1 and REMIX-2 Data Demonstrated Efficacy of Remibrutinib in Chronic Spontaneous Urticaria

March 13th 2024

Latest Videos

All News

© 2024 MJH Life Sciences

All rights reserved.